Literature DB >> 2439485

Phenotypes of HeLa S3 variant cell lines resistant to growth inhibition by sodium butyrate.

A Milsted, D L Day, J Pensky, R P Cox.   

Abstract

HeLa cell variants capable of multiplying in the presence of sodium butyrate were used to study the relationship of cell cycle position to human chorionic gonadotropin (hCG) production and regulation of the genes encoding hCG alpha- and beta-subunits. The butyrate-resistant variants exhibit several different stable phenotypes. In wild-type HeLa cells, butyrate arrests cell division and modulates synthesis of alpha- and beta-subunits of glycoprotein hormones by coordinately regulating steady-state levels of their respective mRNAs. Because the variant cell lines replicate, in addition to producing hCG subunits in the presence of butyrate, cell cycle arrest does not seem to be a requirement for expression of glycoprotein hormone genes. Studies of histone modification suggest that neither hyperacetylation of histones H3 and H4 nor dephosphorylation of histones H1 and H2A mediates inhibition of cell replication. In the variants, alpha-subunit and hCG beta levels are independently regulated, as a consequence of independent regulation of alpha- and beta-hCG mRNA levels. Long-term effects of butyrate include derepression of some genes (hCG beta in the variant AO) and repression of others (hCG alpha in variant AO). Moreover, hormone production correlates with the steady-state levels of mRNA for each of the subunits, suggesting that regulation occurs before translation. These findings indicate that the butyrate-resistant variant cell lines are valuable for studies of the molecular mechanisms involved in regulation of expression of ectopic hormones.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439485     DOI: 10.1007/bf02623854

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  21 in total

1.  Effect of sodium butyrate on mammalian cells in culture: a review.

Authors:  K N Prasad; P K Sinha
Journal:  In Vitro       Date:  1976-02

2.  n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells.

Authors:  M G Riggs; R G Whittaker; J R Neumann; V M Ingram
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

3.  Relation of cell cycle position and chromatin decondensation to ectopic hormone synthesis in HeLa cells.

Authors:  R J Fallon; R P Cox
Journal:  Somatic Cell Genet       Date:  1981-03

4.  Structure of chromatin containing extensively acetylated H3 and H4.

Authors:  R T Simpson
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

5.  Content of gonadotropins in cultured human malignant cells and effects of sodium butyrate treatment on gonadotropin secretion by HeLa cells.

Authors:  R W Ruddon; C Anderson; K S Meade; P H Aldenderfer; P D Neuwald
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

6.  Regulation of the synthesis of human chorionic gonadotropin by strains of HeLa cells in culture.

Authors:  J Y Chou
Journal:  In Vitro       Date:  1978-09

7.  Coordinate regulation of the messenger ribonucleic acids encoding the alpha- and beta-subunits of human chorionic gonadotropin in HeLa cells and butyrate-resistant variants.

Authors:  A Milsted; B J Silver; R P Cox; J H Nilson
Journal:  Endocrinology       Date:  1985-11       Impact factor: 4.736

Review 8.  Effects of sodium butyrate, a new pharmacological agent, on cells in culture.

Authors:  J Kruh
Journal:  Mol Cell Biochem       Date:  1982-02-05       Impact factor: 3.396

9.  Concentration-dependent effects of sodium butyrate in Chinese hamster cells: cell-cycle progression, inner-histone acetylation, histone H1 dephosphorylation, and induction of an H1-like protein.

Authors:  J A D'Anna; R A Tobey; L R Gurley
Journal:  Biochemistry       Date:  1980-06-10       Impact factor: 3.162

10.  Cell cycle analysis of sodium butyrate and hydroxyurea, inducers of ectopic hormone production in HeLa cells.

Authors:  R J Fallon; R P Cox
Journal:  J Cell Physiol       Date:  1979-08       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.